Pilulka Competitors

Stocks . Czech Republic . 
Stock . Pilulka Lekarny as
PINK Stock  CZK 199.00  4.00  2.05%   
Pilulka Lekarny as competes with Cez AS, Kofola CeskoSlovensko, MT 1997, HARDWARIO, and Coloseum Holding; as well as few others. The company operates under Healthcare sector and is part of Pharmaceutical Retailers industry. Analyzing Pilulka Lekarny competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Pilulka Lekarny to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Pilulka Lekarny Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Pilulka Lekarny competition on your existing holdings.
  
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pilulka Lekarny's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
196.94199.00201.06
Details
Intrinsic
Valuation
LowRealHigh
185.00187.06218.90
Details
Naive
Forecast
LowNextHigh
201.41203.47205.53
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
189.50221.22252.94
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Pilulka Lekarny. Your research has to be compared to or analyzed against Pilulka Lekarny's peers to derive any actionable benefits. When done correctly, Pilulka Lekarny's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Pilulka Lekarny as.

Pilulka Lekarny Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Pilulka Lekarny and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Pilulka and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Pilulka Lekarny as does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
FIXED
+ 0.7
BEZVA
FIXED
+ 0.63
PRIUA
COLOS
+ 0.62
BEZVA
PRIUA
+ 0.61
BEZVA
FIXED
+ 0.59
KOFOL
FIXED
+ 0.54
KLIKY
  
High negative correlations   
FILL
- 0.38
FIXED
FIXED
- 0.37
HWIO
HWIO
- 0.37
KOFOL
BEZVA
- 0.34
HWIO
FILL
- 0.33
KOFOL
FILL
- 0.3
BEZVA

Risk-Adjusted Indicators

There is a big difference between Pilulka Stock performing well and Pilulka Lekarny Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pilulka Lekarny's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CEZ  1.12 (0.12) 0.00 (0.58) 0.00 
 0.00 
 2.70 
(2.41)
 9.85 
KOFOL  0.69 (0.04) 0.00 (0.16) 0.00 
 0.00 
 1.48 
(1.47)
 4.77 
KLIKY  0.42 (0.13) 0.00  2.58  0.00 
 0.00 
 0.00 
(1.95)
 5.26 
HWIO  2.01  0.08  0.00 (0.56) 2.34 
(3.23)
 6.03 
(5.08)
 13.80 
BEZVA  1.23 (0.04) 0.00  2.24  0.00 
 0.00 
 2.94 
(3.45)
 9.88 
COLOS  2.59 (0.01) 0.00  0.05  4.57 
(10.75)
 14.17 
(9.68)
 46.21 
PRIUA  1.92 (0.19) 0.00 (0.10) 0.00 
 0.00 
 5.83 
(4.76)
 15.57 
PRAB  0.91 (0.10) 0.00 (0.05) 0.00 
 0.00 
 2.59 
(3.36)
 15.88 
FIXED  1.16 (0.15) 0.00  0.41  0.00 
 0.00 
 3.23 
(3.39)
 8.89 
FILL  0.57 (0.01) 0.00 (0.23) 0.00 
 0.00 
 0.66 
 0.00 
 18.75 

Pilulka Lekarny Competitive Analysis

The better you understand Pilulka Lekarny competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Pilulka Lekarny's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Pilulka Lekarny's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
PINK CEZ KOFOL KLIKY HWIO BEZVA COLOS PRIUA PRAB FIXED
 2.05 
 199.00 
Pilulka
 0.68 
 874.00 
Cez
 1.49 
 273.00 
Kofola
 2.70 
 28,800 
KLIKY
 4.46 
 11.70 
HARDWARIO
 0.70 
 705.00 
Bezvavlasy
 7.69 
 140.00 
Coloseum
 1.64 
 900.00 
Primoco
 3.36 
 230.00 
Prabos
 4.61 
 159.00 
FIXEDzone
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Somewhat reliable
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Weak
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Low
Low
Low
About Average
Low
Below Average
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Cautious Hold
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Hold
Strong Sell
Return On Asset
N/A
0.0306
0.0346
N/A
0.0825
N/A
N/A
-0.25
0.14
N/A
Book Value Per Share
N/A
163.41
63.07
N/A
N/A
N/A
N/A
17.92
190.95
N/A
Profit Margin
N/A
0.2
0.0304
N/A
0.17
N/A
N/A
-2.11
0.13
N/A
EBITDA
N/A
106.92 B
874.6 M
N/A
6.5 M
N/A
N/A
(24.78 M)
78.85 M
N/A
Current Valuation
1.64 B
542.98 B
8.16 B
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Book
22.39
4.77
3.84
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
0.25
0.0551
N/A
0.24
N/A
N/A
-2.07
0.15
N/A
Target Price
1120.0
975.8
337.0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Last Dividend Paid
N/A
44.0
11.3
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
N/A
4.2
2.6
N/A
N/A
N/A
N/A
6.8
6.0
N/A
Market Capitalization
1.78 B
524.98 B
5.37 B
371.2 M
N/A
N/A
129.33 M
2 B
164 M
N/A
Beta
N/A
0.51
0.56
N/A
N/A
N/A
N/A
0.37
0.12
N/A
Price To Sales
1.47
1.47
0.68
N/A
N/A
N/A
N/A
131.35
0.48
N/A
Number Of Employees
2
27.5 K
2.04 K
N/A
3
N/A
N/A
32
219
N/A
Shares Outstanding
2.5 M
536.79 M
21.23 M
12.8 K
N/A
N/A
862.2 K
4.71 M
1000 K
N/A
Earnings Per Share
N/A
106.1
10.28
N/A
N/A
N/A
N/A
-5.94
54.3
N/A
Annual Yield
N/A
0.0491
0.0452
N/A
N/A
N/A
N/A
N/A
0.0373
N/A
Return On Equity
N/A
0.41
0.15
N/A
0.29
N/A
N/A
-0.53
0.32
N/A
Shares Owned By Insiders
N/A
69.7
71.98
N/A
N/A
N/A
N/A
85.0
N/A
N/A
Revenue
N/A
280.45 B
7.63 B
N/A
17.62 M
N/A
N/A
13.27 M
432.52 M
N/A
Gross Profit
N/A
102.01 B
2.93 B
N/A
6.66 M
N/A
N/A
(16.49 M)
175.3 M
N/A
Day Typical Price
198.33
873.5
273.0
29066.67
11.5
705.0
140.0
886.67
232.67
159.0
Accumulation Distribution
0.0101
0.0142
0.0145
0.027
0.0513
N/A
N/A
0.0444
0.0336
N/A
Market Facilitation Index
2.0
12.5
4.0
800.0
0.6
N/A
N/A
40.0
8.0
N/A
Daily Balance Of Power
2.0
(0.48)
1.0
(1.00)
0.8333
(9,223,372,036,855)
9.2 T
(0.38)
(1.00)
9.2 T
Period Momentum Indicator
4.0
(6.00)
4.0
(800.00)
0.5
(5.00)
10.0
(15.00)
(8.00)
7.0
Rate Of Daily Change
1.02
0.99
1.01
0.97
1.04
0.99
1.08
0.98
0.97
1.05
Day Median Price
198.0
873.25
273.0
29200.0
11.4
705.0
140.0
880.0
234.0
159.0
Price Action Indicator
3.0
(2.25)
2.0
(800.00)
0.55
(2.50)
5.0
12.5
(8.00)
3.5
Coefficient Of Variation
(398.81)
(1,568)
(5,306)
(650.26)
3599.01
(6,078)
12670.43
(2,591)
(5,909)
(1,100)
Mean Deviation
1.56
1.12
0.6943
0.4222
2.01
1.23
2.59
1.92
0.9115
1.16
Jensen Alpha
(0.56)
(0.12)
(0.04)
(0.13)
0.0807
(0.04)
(0.01)
(0.19)
(0.10)
(0.15)
Total Risk Alpha
(0.72)
(0.26)
(0.12)
(0.22)
(0.21)
(0.23)
(0.57)
(0.38)
(0.26)
(0.36)
Sortino Ratio
N/A
N/A
N/A
N/A
0.0044
N/A
(0)
N/A
N/A
N/A
Downside Variance
N/A
N/A
N/A
N/A
10.65
N/A
149.04
N/A
N/A
N/A
Standard Deviation
2.06
1.59
0.9386
0.829
2.99
2.0
6.49
2.77
2.28
1.88
Kurtosis
0.4383
2.65
0.3656
5.63
0.68
2.0
6.72
1.4
9.73
1.39
Potential Upside
2.7
2.7
1.48
N/A
6.03
2.94
14.17
5.83
2.59
3.23
Treynor Ratio
(0.83)
(0.58)
(0.16)
2.58
(0.56)
2.24
0.0467
(0.1)
(0.05)
0.4056
Maximum Drawdown
9.89
9.85
4.77
5.26
13.8
9.88
46.21
15.57
15.88
8.89
Variance
4.24
2.54
0.881
0.6872
8.93
4.02
42.07
7.65
5.18
3.52
Market Risk Adjusted Performance
(0.82)
(0.57)
(0.15)
2.59
(0.55)
2.25
0.0567
(0.09)
(0.04)
0.4156
Risk Adjusted Performance
(0.15)
(0.03)
(0.01)
(0.09)
0.0251
(0)
0.0139
(0.02)
(0)
(0.05)
Skewness
(0.46)
(0.61)
(0.26)
(0.18)
0.3877
(0.09)
0.6155
0.3637
(0.91)
0.4248
Semi Deviation
N/A
N/A
N/A
N/A
2.34
N/A
4.57
N/A
N/A
N/A
Information Ratio
(0.28)
(0.11)
(0.09)
(0.24)
0.0048
(0.05)
(0)
(0.06)
(0.05)
(0.13)
Value At Risk
(4.55)
(2.41)
(1.47)
(1.95)
(5.08)
(3.45)
(9.68)
(4.76)
(3.36)
(3.39)
Expected Short fall
N/A
N/A
N/A
N/A
(3.23)
N/A
(10.75)
N/A
N/A
N/A
Downside Deviation
N/A
N/A
N/A
N/A
3.26
N/A
12.21
N/A
N/A
N/A
Semi Variance
N/A
N/A
N/A
N/A
5.48
N/A
20.87
N/A
N/A
N/A

Pilulka Lekarny Competition Performance Charts

Five steps to successful analysis of Pilulka Lekarny Competition

Pilulka Lekarny's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Pilulka Lekarny as in relation to its competition. Pilulka Lekarny's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Pilulka Lekarny in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Pilulka Lekarny's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Pilulka Lekarny as, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Pilulka Lekarny position

In addition to having Pilulka Lekarny in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run World Allocation Funds Thematic Idea Now

World Allocation Funds
World Allocation Funds Theme
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Pilulka Lekarny Correlation with its peers.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Pilulka Stock analysis

When running Pilulka Lekarny's price analysis, check to measure Pilulka Lekarny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pilulka Lekarny is operating at the current time. Most of Pilulka Lekarny's value examination focuses on studying past and present price action to predict the probability of Pilulka Lekarny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pilulka Lekarny's price. Additionally, you may evaluate how the addition of Pilulka Lekarny to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bonds Directory
Find actively traded corporate debentures issued by US companies
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Pilulka Lekarny's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pilulka Lekarny is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pilulka Lekarny's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY